Fulcrum Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. | 11/14/2024 | 10.23 M | $36.52 M | -11.89% | 16.39% |
| BLACKROCK FUNDING, INC. /DE | 11/13/2024 | 5.71 M | $20.37 M | 100.00% | 9.14% |
| TCG CROSSOVER MANAGEMENT, LLC | 11/14/2024 | 5.25 M | $18.74 M | 100.00% | 8.41% |
| NANTAHALA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 4.78 M | $17.06 M | 100.00% | 7.66% |
| VANGUARD GROUP INC | 11/13/2024 | 3.27 M | $11.69 M | 6.62% | 5.25% |
| TRV GP IV, LLC | 11/06/2024 | 2.34 M | $8.37 M | 0.00% | 3.75% |
| CAPTION MANAGEMENT, LLC | 11/14/2024 | 2.21 M | $7.90 M | 6.17% | 3.55% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2024 | 2.00 M | $7.14 M | 566.67% | 3.20% |
| FMR LLC | 11/13/2024 | 1.72 M | $6.15 M | -67.65% | 2.76% |
| STATE STREET CORP | 11/14/2024 | 1.68 M | $6.00 M | 61.36% | 2.69% |
| PERCEPTIVE ADVISORS LLC | 11/14/2024 | 1.50 M | $5.36 M | 100.00% | 2.40% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2024 | 1.50 M | $5.36 M | 0.00% | 2.40% |
| DIMENSIONAL FUND ADVISORS LP | 11/07/2024 | 1.42 M | $5.08 M | -3.88% | 2.28% |
| CITADEL ADVISORS LLC | 11/14/2024 | 1.35 M | $4.82 M | -24.10% | 2.16% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2024 | 1.32 M | $4.72 M | 1.03% | 2.12% |
| CAPTION MANAGEMENT, LLC | 11/14/2024 | 1.20 M | $4.30 M | 473.48% | 1.93% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 11/14/2024 | 1.18 M | $4.22 M | -53.45% | 1.90% |
| BRAIDWELL LP | 11/14/2024 | 1.07 M | $3.82 M | 100.00% | 1.71% |
| GOLDMAN SACHS GROUP INC | 11/14/2024 | 927,961 | $3.31 M | 65.56% | 1.49% |
| D. E. SHAW & CO., INC. | 11/14/2024 | 757,731 | $2.71 M | 28.04% | 1.21% |
| WOODLINE PARTNERS LP | 11/14/2024 | 670,807 | $2.39 M | 33.81% | 1.07% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/12/2024 | 569,185 | $2.03 M | 223.43% | 0.91% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 556,900 | $1.99 M | 324.14% | 0.89% |
| IKARIAN CAPITAL, LLC | 11/14/2024 | 422,800 | $1.51 M | 100.00% | 0.68% |
| TWO SIGMA ADVISERS, LP | 11/14/2024 | 382,200 | $1.36 M | -32.17% | 0.61% |
| SIMPLIFY ASSET MANAGEMENT INC. | 11/12/2024 | 351,314 | $1.25 M | -47.94% | 0.56% |
| MORGAN STANLEY | 11/14/2024 | 350,685 | $1.25 M | -71.60% | 0.56% |
| ASSENAGON ASSET MANAGEMENT S.A. | 10/23/2024 | 340,495 | $1.22 M | -31.55% | 0.55% |
| CAPTION MANAGEMENT, LLC | 11/14/2024 | 307,414 | $1.10 M | -41.48% | 0.49% |
| SHAY CAPITAL LLC | 11/14/2024 | 289,237 | $1.03 M | 100.00% | 0.46% |
| BESSEMER GROUP INC | 11/12/2024 | 286,988 | $1.03 M | 0.00% | 0.46% |
| TWO SIGMA INVESTMENTS, LP | 11/14/2024 | 272,107 | $971,422 | -46.61% | 0.44% |
| SHERBROOKE PARK ADVISERS LLC | 11/14/2024 | 227,225 | $811,193 | 100.00% | 0.36% |
| MASS GENERAL BRIGHAM, INC | 10/16/2024 | 205,356 | $733,121 | 0.00% | 0.33% |
| CITADEL ADVISORS LLC | 11/14/2024 | 202,200 | $721,854 | 705.58% | 0.32% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 11/14/2024 | 202,030 | $721,247 | 100.00% | 0.32% |
| CITADEL ADVISORS LLC | 11/14/2024 | 195,000 | $696,150 | 68.54% | 0.31% |
| ACADIAN ASSET MANAGEMENT LLC | 11/12/2024 | 188,961 | $674,000 | 100.00% | 0.30% |
| JPMORGAN CHASE & CO | 12/26/2024 | 187,163 | $668,173 | 466.46% | 0.30% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2024 | 176,161 | $628,895 | -3.59% | 0.28% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11/14/2024 | 171,200 | $611,184 | 100.00% | 0.27% |
| NUVEEN ASSET MANAGEMENT, LLC | 11/14/2024 | 169,549 | $605,290 | 0.00% | 0.27% |
| HAP TRADING, LLC | 11/12/2024 | 163,200 | $59,843 | 100.00% | 0.26% |
| HAP TRADING, LLC | 11/12/2024 | 147,300 | $2,336 | 194.60% | 0.24% |
| BANK OF NEW YORK MELLON CORP | 11/12/2024 | 138,747 | $495,327 | -25.70% | 0.22% |
| FIDUCIARY TRUST CO | 11/14/2024 | 136,555 | $487,501 | 0.00% | 0.22% |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | 11/08/2024 | 132,784 | $474,039 | 100.00% | 0.21% |
| BOOTHBAY FUND MANAGEMENT, LLC | 11/14/2024 | 129,100 | $460,887 | 100.00% | 0.21% |
| BARCLAYS PLC | 11/19/2024 | 124,141 | $443,000 | 367.12% | 0.20% |
| ALPS ADVISORS INC | 11/12/2024 | 123,009 | $439,142 | 153.74% | 0.20% |
Fulcrum Therapeutics, Inc.institutional Ownership - FAQ's
During the previous two years, 164 institutional investors and hedge funds held shares of Fulcrum Therapeutics, Inc.. The most heavily invested institutionals were:
RA CAPITAL MANAGEMENT, L.P.: 10.23 M
BlackRock Funding, Inc. /DE: 5.71 M
TCG Crossover Management, LLC: 5.25 M
Nantahala Capital Management, LLC: 4.78 M
VANGUARD GROUP INC: 3.27 M
TRV GP IV, LLC: 2.34 M
87.76% of Fulcrum Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 58.88 M shares in the last 24 months. This purchase volume represents approximately $280.88 M in transactions.